Ondansetron in treatment of schizophrenia
- 1 May 1991
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 337 (8750), 1173
- https://doi.org/10.1016/0140-6736(91)92851-r
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brainBritish Journal of Pharmacology, 1987